Atlas Trials

Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma

Clinical trial NCT04609579 · TERMINATED

Trial details

NCT number
NCT04609579
Sponsor
Stingthera, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorAdvanced Lymphoma
Start date
2020-11-18
Primary completion
2024-01-06
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.